Global Intravenous Injection Immunoglobulin Market Growth 2022-2028

As the global economy mends, the 2021 growth of Intravenous Injection Immunoglobulin will have significant change from previous year. According to our researcher's latest study, the global Intravenous Injection Immunoglobulin market size is USD million in 2022 from USD 10090 million in 2021, with a change of % between 2021 and 2022. The global Intravenous Injection Immunoglobulin market size will reach USD 15160 million in 2028, growing at a CAGR of 6.0% over the analysis period.
The United States Intravenous Injection Immunoglobulin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Intravenous Injection Immunoglobulin market, reaching US$ million by the year 2028. As for the Europe Intravenous Injection Immunoglobulin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Intravenous Injection Immunoglobulin players cover Boya-Bio, Beijing Tiantan Biological Products, Hualan Bio, and Guangdong Shuagnlin Bio-pharmacy, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Injection Immunoglobulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
1g/20ml
1.25g/25ml
2.5g/50ml
5g/100ml
10g/200ml
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Boya-Bio
Beijing Tiantan Biological Products
Hualan Bio
Guangdong Shuagnlin Bio-pharmacy
Weiguang Biological
Sinopharm
Shanghai RAAS
CTBB
Nanyue Biopharming